pH-sensitive pHLIP^® coated niosomes

References

• Ammar H, Ghorab M, El-Nahhas S, Higazy I. 2011. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–152.
   PubMed Web of Science ®Google Scholar
• Anderson M, Moshnikova A, Engelman DM, Reshetnyak YK, Andreev OA. 2016. Probe for the measurement of cell surface pH in vivo and ex vivo. Proc Natl Acad Sci USA 113:8177–8181.
   PubMed Web of Science ®Google Scholar
• Andreev OA, Engelman DM, ReshetnyakYK. 2009. Targeting acidic diseased tissue: new technology based on use of the pH (Low) Insertion Peptide (pHLIP). Chim Oggi Chem Today 27:34.
   PubMed Web of Science ®Google Scholar
• Andreev OA, Engelman DM, Reshetnyak YK . 2010. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents. Molec Membrane Biol 27:341–352.
   PubMed Web of Science ®Google Scholar
• Arachige MC, Reshetnyak YK, Andreev OA. 2015. Advanced targeted nanomedicine. J Biotechnol 202:88–97.
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, et al. 2009. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm377:1–8.
   PubMed Web of Science ®Google Scholar
• Calorini L, Peppicelli S, Bianchini F. 2012. Extracellular acidity as favouring factor of tumor progression and metastatic dissemination. Exp Oncol 34:79–84.
   PubMedGoogle Scholar
• Chu CJ, Dijkstra J,Lai MZ, Hong K, Szoka FC. 1990. Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharm Res 7:824–834.
   PubMed Web of Science ®Google Scholar
• Cottrell T, Van PEIJ J. 2004. 7 Sorbitan esters and polysorbates. Emulsifiers in Food Technology. Oxford, UK: Blackwell Publishing Ltd.
   Google Scholar
• Dawidczyk CM, Russell LM, Searson PC. 2014. Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments. Front Chem 2:69.
   PubMed Web of Science ®Google Scholar
• De Sousa Lobato KB, Paese K, Forgearini JC, GUuterres SS, Jablonski A, et al. 2013. Characterisation and stability evaluation of bixin nanocapsules. Food Chem 141:3906–3912.
   PubMed Web of Science ®Google Scholar
• Du JZ, Mao CQ, Yuan YY, Yang XZ, Wang J. 2014. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy. Biotechnol Adv 32:789–803.
   PubMed Web of Science ®Google Scholar
• Emmetiere F, Irwin C, Viola-Villegas N, Longo V, Cheal S, Zanzonico P, et al. 2013. F-Labeled-Bioorthogonal Liposomes for. Vivo. Bioconjugate Chem 24:1784–1789.
   Google Scholar
• Fang JS, Gillies RD, Gatenby RA. 2008. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Seminars in Cancer Biology. Netherlands: Elsevier.
   Google Scholar
• Ghanbarzadeh S, Khorrami A, Arami S. 2015. Nonionic surfactant-based vesicular system for transdermal drug delivery. Drug Deliv 22:1071–1077.
   PubMed Web of Science ®Google Scholar
• Gillies RJ, Robey I, Gatenby RA. 2008. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49:24S–42S.
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. 2005. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82.
   PubMed Web of Science ®Google Scholar
• Han L, Ma H, Guo Y, Kuang Y, He X, Jiang C. 2013. pH‐Controlled Delivery of Nanoparticles into Tumor Cells. Adv Healthc Mater 2:1435–1439.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, Yang Y, Li KA. 2002. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80.
   PubMed Web of Science ®Google Scholar
• Hunter C, Dolan T, Coombs G, Baillie A. 1988. Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J Pharma Pharmacol 40:161–165
   Google Scholar
• Israelachvili J, Marcelja S, Horn R. 1980. Physical principles of membrane organization. Q Rev of Biophys 13:121–200.
   PubMed Web of Science ®Google Scholar
• Jadon PS, Gajbhiye V, Jadon RS, Gajbhiye KR, Ganesh N. 2009. Enhanced oral bioavailability of griseofulvin via niosomes. AAPS PharmSciTech 10:1186.
   PubMed Web of Science ®Google Scholar
• Janic B, Bhuiyan MP, Ewing JR, Ali MM. 2016. pH-Dependent cellular internalization of paramagnetic nanoparticle. ACS Sens 1:975.
   PubMed Web of Science ®Google Scholar
• Karanth H, Murthy R. 2007. pH-sensitive liposomes-principle and application in cancer therapy . J Pharm Pharmacol 59:469–483.
   PubMed Web of Science ®Google Scholar
• Karim KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, et al. 2010. Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 1:374.
   PubMedGoogle Scholar
• Kerwin BA. 2008. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. J Pharm Sci 97:2924–2935.
   PubMed Web of Science ®Google Scholar
• Kishore RS, Pappenberger A, Dauphin IB, Ross A, Buergi B, Stampfli A, et al. 2011. Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis. J Pharm Sci 100:721–731.
   PubMed Web of Science ®Google Scholar
• Koo B, Becker LE, Chuang S, Merante F, Robinson BH, et al. 1993. Mitochondrial encephalomyopathy, lactic acidosis, stroke‐like episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann Neurol 34:25–32. [f][https://doi.org/10.1002/ana.410340107]
   PubMed Web of Science ®Google Scholar
• Lee RJ, Wang S, Turk MJ, Low PS. 1998. The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery. Bioscience Rep 18:69–78.
   PubMed Web of Science ®Google Scholar
• Liu H, Tu L, Zhou Y, Dang Z, Wang L, Du J, et al. 2017. Improved bioavailability and antitumor effect of docetaxel by TPGS modified proniosomes: in Vitro and in Vivo evaluations. Scic Rep 7:43372. doi: 10.1038/srep43372.
   PubMed Web of Science ®Google Scholar
• Lo CT, Jahn A, Locascio LE, Vreeland WN. 2010. Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing. Langmuir 26:8559–8566.
   PubMed Web of Science ®Google Scholar
• Lohumi A. 2012. A novel drug delivery system: niosomes review. J Drug Dev 2:129–135.
   Google Scholar
• Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, et al. 2014. Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci 205:187–206.
   PubMed Web of Science ®Google Scholar
• Mizock BA, Falk JL. 1992. Lactic acidosis in critical illness. CritCare Med 20:80–93.
   PubMed Web of Science ®Google Scholar
• Moghassemi S, Hadjizadeh A. 2014. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release 185:22–36.
   PubMed Web of Science ®Google Scholar
• Nuutila J, Lilius EM. 2005. Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells. Cytometry A 65:93–102.
   PubMed Web of Science ®Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. 2007. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–141.
   PubMed Web of Science ®Google Scholar
• Rajamäki K, Nordströmö T, Nurmi K, Åkerman KE, Kovanen PT, Öörni K, et al. 2013. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome. J Biol Chem 288:13410–13419.
   PubMed Web of Science ®Google Scholar
• Rajera R, Nagpal K, Singh SK, Mishra DN. 2011. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull 34:945–953.
   PubMed Web of Science ®Google Scholar
• Reshetnyak YK, Andreev OA, Lehnert U, Engleman DM. 2006. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proc Natl Aca Sci U.S.A 103:6460–6465.
   PubMed Web of Science ®Google Scholar
• Reshetnyak YK, Andreev OA, Segala M, Markin VS, Englemann DM. 2008. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc Natl Aca Sci U.S.A 105:15340–15345.
   PubMed Web of Science ®Google Scholar
• Reshetnyak YK, Segala M, Andreev OA, Engelmann DM. 2007. A monomeric membrane peptide that lives in three worlds: in solution, attached to and inserted across lipid bilayers. Biophysl J 93:2363–2372.
   PubMed Web of Science ®Google Scholar
• Sahoo RK, Biswas N, Guha A, Sahoo N, Kuotsu K. 2014. Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives. BioMed Res Int 2014:263604. doi: 10.1155/2014/263604.
   PubMed Web of Science ®Google Scholar
• Smith LL. 1981. Cholesterol autoxidation, Springer Science & Business Media New York, USA.
   Google Scholar
• Stingl J, Caldas C. 2007. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7:791–799.
   PubMed Web of Science ®Google Scholar
• Stubbs M, Mcsheeny PM, Griffiths JR, Bashford CL. 2000. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 6:15–19.
   PubMedGoogle Scholar
• Subbarao NK, Parente RA, Szoka FC, JR, Nadasdi L, PONGRACZ K. 1987. The pH-dependent bilayer destabilization by an amphipathic peptide. J Biochem 26:2964–2972.
   Web of Science ®Google Scholar
• Tian Y, Zhang Y, Teng Z, Tian W, Luo S, Kong X, et al. 2017. pH-dependent transmembrane a of peptide-functionalized gold nanostars for computed tomography/photoacoustic imaging and photothermal therapy. ACS Appl Mater Interfaces 9:2114–2122.
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033.
   PubMed Web of Science ®Google Scholar
• Weerakkody D, Mooshnikova A, Thakur MS, Moshnikova V, Daniels J, Engelman DM, et al. 2013. Family of pH (low) insertion peptides for tumor targeting. Proc. Nat Acad Sci USA 110:5834–5839.
   PubMed Web of Science ®Google Scholar
• Wei Y, Liao R, Mahmood AA, Xu H, Zhou Q. 2017. pH-Responsive pHLIP (pH Low Insertion Peptide) Nanoclusters of Superparamagnetic Iron Oxide Nanoparticles as a Tumor-selective MRI Contrast Agent. Acta Biomater 55:194–203.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL, Vant Veer LJ. 2005. Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591–602.
   PubMed Web of Science ®Google Scholar
• Wijesinghe D, Arachchige MC, Lu A, Reshetnyak YK, Andreev OA. 2013. pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis. Sci Rep 3:3560. doi: 10.1038/srep03560.
   PubMed Web of Science ®Google Scholar
• Yao L, Daniels J, Moshnikova A, Kuznetsov S, Ahmed A, Engelman DM, et al. 2013a. pHLIP peptide targets nanogold particles to tumors. Proc. Nat Acad Sci U.S.A 110:465–470.
   PubMed Web of Science ®Google Scholar
• Yao L, Daniels J, Wijesinghe D, Andreev OA, Reshetnyak YK. 2013b. pHLIP®-mediated delivery of PEGylated liposomes to cancer cells. J Control Release 167:228–237.
   PubMed Web of Science ®Google Scholar
• Yu M, Guo F, Wang J, Tan F, Li N. 2015. Photosensitizer-loaded pH-responsive hollow gold nanospheres for single light-induced photothermal/photodynamic therapy. ACS Applied Materials & Interfaces7:17592–17597.
   PubMed Web of Science ®Google Scholar
• Yu M, Guo F, Wang J, Tan F, Li N. 2016. A pH-Driven and photoresponsive nanocarrier: Remotely-controlled by near-infrared light for stepwise antitumor treatment. Biomaterials 79:25–35.
   PubMed Web of Science ®Google Scholar